Posts filed under:

Three Ways to Pandemic-Proof Your Facility

The COVID-19 pandemic has shone a spotlight on a challenge that has already been at the center of biotech facility design for years: viral containment. In order to keep both operators and end-user patients safe, biotech facility architects regularly employ the strategies of segregation, cleanability, and automation/process closure for the sake of safety. Due to the effects of COVID-19 pandemic, there is potential for safety solutions that are commonplace and pandemic-proof in biotech ATMP projects to transfer into unrelated commercial design projects.

Read More


see all